152 related articles for article (PubMed ID: 36702355)
1. Diagnostic clues of BCL2-negative, faint, or controversial follicular lymphomas: a study of 103 cases.
Maeshima AM; Taniguchi H; Furukawa H; Hattori D; Sasaki H; Makita S; Iwaki N; Fukuhara S; Munakata W; Izutsu K
Hum Pathol; 2023 May; 135():84-92. PubMed ID: 36702355
[TBL] [Abstract][Full Text] [Related]
2. Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.
Horn H; Schmelter C; Leich E; Salaverria I; Katzenberger T; Ott MM; Kalla J; Romero M; Siebert R; Rosenwald A; Ott G
Haematologica; 2011 Sep; 96(9):1327-34. PubMed ID: 21659362
[TBL] [Abstract][Full Text] [Related]
3. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.
Adam P; Baumann R; Schmidt J; Bettio S; Weisel K; Bonzheim I; Fend F; Quintanilla-Martínez L
Hum Pathol; 2013 Sep; 44(9):1817-26. PubMed ID: 23642737
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N
Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
[TBL] [Abstract][Full Text] [Related]
7. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.
Karube K; Guo Y; Suzumiya J; Sugita Y; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Takeshita M; Kikuchi M; Nakamura N; Takasu O; Arakawa F; Tagawa H; Seto M; Ohshima K
Blood; 2007 Apr; 109(7):3076-9. PubMed ID: 17138820
[TBL] [Abstract][Full Text] [Related]
8. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.
Guo Y; Karube K; Kawano R; Yamaguchi T; Suzumiya J; Huang GS; Ohshima K
Leukemia; 2005 Jun; 19(6):1058-63. PubMed ID: 15815725
[TBL] [Abstract][Full Text] [Related]
9. Follicular lymphoma in Taiwan: a low frequency of t(14;18), with grade 3A tumours more closely related to grade 3B than to low-grade tumours.
Chang ST; Lu YH; Lu CL; Kuo SY; Liu H; Lin SH; Win KT; Hsieh YC; Chuang SS
Histopathology; 2013 Jul; 63(1):1-12. PubMed ID: 23631722
[TBL] [Abstract][Full Text] [Related]
10. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements.
Ikoma H; Miyaoka M; Hiraiwa S; Yukie Kikuti Y; Shiraiwa S; Hara R; Kojima M; Ohmachi K; Ando K; Carreras J; Nakamura N
Pathol Int; 2022 Jun; 72(6):321-331. PubMed ID: 35297566
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.
Leich E; Zamo A; Horn H; Haralambieva E; Puppe B; Gascoyne RD; Chan WC; Braziel RM; Rimsza LM; Weisenburger DD; Delabie J; Jaffe ES; Fitzgibbon J; Staudt LM; Mueller-Hermelink HK; Calaminici M; Campo E; Ott G; Hernández L; Rosenwald A
Blood; 2011 Nov; 118(20):5550-8. PubMed ID: 21960592
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
[TBL] [Abstract][Full Text] [Related]
15. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
[TBL] [Abstract][Full Text] [Related]
16. Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.
Leich E; Hoster E; Wartenberg M; Unterhalt M; Siebert R; Koch K; Klapper W; Engelhard M; Puppe B; Horn H; Staiger AM; Stuhlmann-Laeisz C; Bernd HW; Feller AC; Hummel M; Lenze D; Stein H; Hartmann S; Hansmann ML; Möller P; Hiddemann W; Dreyling M; Ott G; Rosenwald A;
Leukemia; 2016 Apr; 30(4):854-60. PubMed ID: 26621338
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups.
Ozsan N; Bedke BJ; Law ME; Inwards DJ; Ketterling RP; Knudson RA; Keeney GL; Dogan A; Feldman AL
Am J Surg Pathol; 2011 Nov; 35(11):1691-9. PubMed ID: 21997689
[TBL] [Abstract][Full Text] [Related]
18. Significance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of BCL2 and BCL6 rearrangements.
Szumera-Ciećkiewicz A; Rymkiewicz G; Sokół K; Paszkiewicz-Kozik E; Borysiuk A; Poleszczuk J; Bachnio K; Bystydzienski Z; Woroniecka R; Grygalewicz B; Kotarska M; Stańczak M; Owczarek D; Pytlak B; Prochorec-Sobieszek M; Walewski J
Int J Lab Hematol; 2020 Aug; 42(4):453-463. PubMed ID: 32364682
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of HGAL and LMO2 immunohistochemistry in the identification of follicular lymphomas of the non-gastric gastrointestinal tract.
Chapman-Fredricks J; Younes SF; Fan YS; Sandoval-Sus JD; Natkunam Y; Lossos IS
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):200-4. PubMed ID: 22914613
[TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses.
Maeshima AM; Omatsu M; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
Cancer Sci; 2008 Sep; 99(9):1760-8. PubMed ID: 18549405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
